Abstract
Designing antagonists to anti-apoptotic proteins of Bcl-2 family has become an important strategy in cancer chemotherapy. Using experimental techniques and computational methods, a few numbers of lead inhibitors to the antiapoptotic proteins have been reported in the literature and a few of them are under clinical trials. In this review, the lead inhibitors designed using in silico methodologies are exclusively covered, systematically organized and critically evaluated. An orchestrated in silico strategy for screening and identifying efficient antagonists to the anti-apoptotic proteins has also been brought into fore.
Keywords: Apoptosis, Bcl-2 family proteins, Cancer, Drug designing, In silico tools, Neoplasm and Structural Bioinformatics, in silico, oligomeric structure, pro-apoptotic proteins
Mini-Reviews in Medicinal Chemistry
Title:In silico Methods for Designing Antagonists to Anti-apoptotic Members of Bcl-2 Family Proteins
Volume: 12 Issue: 11
Author(s): Dakshinamurthy Sivakumar, Tambi Richa, Sivarathri Siva Rajesh, Biswajit Gorai and Thirunavukkarasu Sivaraman
Affiliation:
Keywords: Apoptosis, Bcl-2 family proteins, Cancer, Drug designing, In silico tools, Neoplasm and Structural Bioinformatics, in silico, oligomeric structure, pro-apoptotic proteins
Abstract: Designing antagonists to anti-apoptotic proteins of Bcl-2 family has become an important strategy in cancer chemotherapy. Using experimental techniques and computational methods, a few numbers of lead inhibitors to the antiapoptotic proteins have been reported in the literature and a few of them are under clinical trials. In this review, the lead inhibitors designed using in silico methodologies are exclusively covered, systematically organized and critically evaluated. An orchestrated in silico strategy for screening and identifying efficient antagonists to the anti-apoptotic proteins has also been brought into fore.
Export Options
About this article
Cite this article as:
Sivakumar Dakshinamurthy, Richa Tambi, Siva Rajesh Sivarathri, Gorai Biswajit and Sivaraman Thirunavukkarasu, In silico Methods for Designing Antagonists to Anti-apoptotic Members of Bcl-2 Family Proteins, Mini-Reviews in Medicinal Chemistry 2012; 12 (11) . https://dx.doi.org/10.2174/138955712802762202
DOI https://dx.doi.org/10.2174/138955712802762202 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design Cytotoxic Nucleoside Analogues: Different Strategies to Improve their Clinical Efficacy
Current Medicinal Chemistry Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21
Current Pharmaceutical Design Use of Anti-Cancer Drugs, Mitocans, to Enhance the Immune Responses against Tumors
Current Pharmaceutical Biotechnology Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Anti-Cancer Agents in Medicinal Chemistry Lipid Based Nanosystems for Curcumin: Past, Present and Future
Current Pharmaceutical Design Linking Inflammation to Cell Cycle Progression
Current Pharmaceutical Design Working Hypothesis: Elimination of Cancer Stem Cells in Solid Tumors by Immuno-Gene Therapy Using Cancer Vaccines and Created-Inhibitory RNA
Current Cancer Therapy Reviews Akt Pathway Inhibitors
Current Topics in Medicinal Chemistry The Frequency of Thrombotic Events Among Adults Given Antifibrinolytic Drugs for Spontaneous Bleeding: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
Current Drug Safety BK Channel Modulators: A Comprehensive Overview
Current Medicinal Chemistry Multiscale Products in B-spline Wavelet Domain: A New Method for Short Exon Detection
Current Bioinformatics Radioembolization of Hepatocellular Carcinoma
Current Drug Discovery Technologies Molecular Basis of Bicarbonate Membrane Transport in the Male Reproductive Tract
Current Medicinal Chemistry Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Non-Invasive Tests in Animal Models and Humans: A New Paradigm for Assessing Efficacy of Biologics Including Prebiotics and Probiotics
Current Pharmaceutical Design Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis Chlorophytum borivilianum: A White Gold for Biopharmaceuticals and Neutraceuticals
Current Pharmaceutical Biotechnology A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
Current Genomics